New insights: A role for O-GlcNAcylation in diabetic complications

Critical Reviews in Biochemistry and Molecular Biology

Volumn 51, Issue 3, 2016, Pages 150-161

  Peterson, Sherket B ^a   Hart, Gerald W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; diabetes; diabetic nephropathy; diabetic retinopathy; glucose toxicity; hexosamine biosynthetic pathway; hyperglycemia; O GlcNAc

Indexed keywords

HEXOSAMINE; HYDROLASE; N ACETYLGLUCOSAMINE; O LINKED BETA N ACETYLGLUCOSAMINE; SERINE; THREONINE; TRANSFERASE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE;

ACYLATION; CELL DIVISION; CYTOSKELETON; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; MOLECULAR DYNAMICS; NONHUMAN; NUTRIENT; O GLCNACYLATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; DIABETIC COMPLICATION; GLYCOSYLATION; METABOLISM;

ACETYLGLUCOSAMINE; ANIMALS; DIABETES COMPLICATIONS; DIABETES MELLITUS; GLYCOSYLATION; HEXOSAMINES; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84958036239     PISSN: 10409238     EISSN: 15497798     Source Type: Journal    
DOI: 10.3109/10409238.2015.1135102     Document Type: Review

References (111)

1. Y.Akimoto, H.Kawakami, K.Yamamoto,. (2003). Elevated expression of O-GlcNAc-modified proteins and O-GlcNAc transferase in corneas of diabetic Goto-Kakizaki rats. Invest Ophthalmol Vis Sci 44:3802–9
2. Y.Akimoto, Y.Miura, T.Toda,. (2011). Morphological changes in diabetic kidney are associated with increased O-GlcNAcylation of cytoskeletal proteins including α-actinin 4. Clin Proteomics 8:15
3. American Diabetes Association. (2013). Economic costs of diabetes in the U.S. in 2012. Diabetes Care 36:1033–46
4. S.S.Andrali, Q.Qian, S.Ozcan (2007). Glucose mediates the translocation of NeuroD1 by O-linked glycosylation. J Biol Chem 282:15589–96
5. D.A.Babu, S.K.Chakrabarti, J.C.Garmey, R.G.Mirmira (2008). Pdx1 and BETA2/NeuroD1 participate in a transcriptional complex that mediates short-range DNA looping at the insulin gene. J Biol Chem 283:8164–72
6. L.E.Ball, M.N.Berkaw, M.G.Buse (2006). Identification of the major site of O-linked beta-N-acetylglucosamine modification in the C terminus of insulin receptor substrate-1. Mol Cell Proteomics 5:313–23
7. P.S.Banerjee, J.Ma, G.W.Hart (2015). Diabetes-associated dysregulation of O-GlcNAcylation in rat cardiac mitochondria. Proc Natl Acad Sci USA, 112:6050–5
8. N.Boute, O.Gribouval, S.Roselli,. (2000). NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24:349–54
9. M.Brownlee (2001). Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–20
10. M.G.Buse (2006). Hexosamines, insulin resistance, and the complications of diabetes: current status. Am J Physiol Endocrinol Metab 290:E1–8
11. C.Butkinaree, K.Park, G.W.Hart (2010). O-linked beta-N-acetylglucosamine (O-GlcNAc): extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress. Biochim Biophys Acta 1800:96–106
12. Y.Q.Chen, M.Su, R.R.Walia,. (1998). Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells. J Biol Chem 273:8225–31
13. W.D.Cheung, K.Sakabe, M.P.Housley,. (2008). O-linked beta-N-acetylglucosaminyltransferase substrate specificity is regulated by myosin phosphatase targeting and other interacting proteins. J Biol Chem 283:33935–41
14. C.F.Chou, M.B.Omary (1993). Mitotic arrest-associated enhancement of O-linked glycosylation and phosphorylation of human keratins 8 and 18. J Biol Chem 268:4465–72
15. E.J.Chung, J.N.Chun, S.A.Jung,. (2011). TGF-β-stimulated aberrant expression of class III β-tubulin via the ERK signaling pathway in cultured retinal pigment epithelial cells. Biochem Biophys Res Commun 415:367–72
16. R.J.Clark, P.M.McDonough, E.Swanson,. (2003). Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation. J Biol Chem 278:44230–7
17. D.G.Cogan, D.Toussaint, T.Kuwabara (1961). Retinal vascular patterns. IV. Diabetic retinopathy. Arch Ophthalmol 66:366–78
18. F.I.Comer, G.W.Hart (1999). O-GlcNAc and the control of gene expression. Biochim Biophys Acta 1473:161–71
19. F.I.Comer, G.W.Hart (2001). Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II. Biochemistry 40:7845–52
20. M.E.Cooper (2001). Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia 44:1957–72
21. R.J.Copeland, J.W.Bullen, G.W.Hart (2008). Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. Am J Physiol Endocrinol Metab 295:E17–28
22. S.M.Dauphinee, M.Ma, C.K.Too (2005). Role of O-linked beta-N-acetylglucosamine modification in the subcellular distribution of alpha4 phosphoprotein and Sp1 in rat lymphoma cells. J Cell Biochem 96:579–88
23. P.Degrell, J.Cseh, M.Mohas,. (2009). Evidence of O-linked N-acetylglucosamine in diabetic nephropathy. Life Sci 84:389–93
24. R.Dentin, S.Hedrick, J.Xie,. (2008). Hepatic glucose sensing via the CREB coactivator CRTC2. Science 319:1402–5
25. K.Donovan, O.Alekseev, X.Qi,. (2014). O-GlcNAc modification of transcription factor Sp1 mediates hyperglycemia-induced VEGF-A upregulation in retinal cells. Invest Ophthalmol Vis Sci 55:7862–73
26. D.B.Donoviel, D.D.Freed, H.Vogel,. (2001). Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN. Mol Cell Biol 21:4829–36
27. X.L.Du, D.Edelstein, L.Rossetti,. (2000). Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA 97:12222–6
28. V.S.Farook, C.Bogardus, M.Prochazka (2002). Analysis of MGEA5 on 10q24.1-q24.3 encoding the beta-O-linked N-acetylglucosaminidase as a candidate gene for type 2 diabetes mellitus in Pima Indians. Mol Genet Metab 77:189–93
29. J.M.Forbes, K.Fukami, M.E.Cooper (2007). Diabetic nephropathy: where hemodynamics meets metabolism. Exp Clin Endocrinol Diabetes 115:69–84
30. M.E.Forsythe, D.C.Love, B.D.Lazarus,. (2006). Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer. Proc Natl Acad Sci USA 103:11952–7
31. N.Fulop, M.M.Mason, K.Dutta,. (2007). Impact of Type 2 diabetes and aging on cardiomyocyte function and O-linked N-acetylglucosamine levels in the heart. Am J Physiol Cell Physiol 292:C1370–8
32. Y.Gao, J.Miyazaki, G.W.Hart (2003). The transcription factor PDX-1 is post-translationally modified by O-linked N-acetylglucosamine and this modification is correlated with its DNA binding activity and insulin secretion in min6 beta-cells. Arch Biochem Biophys 415:155–63
33. Y.Gao, L.Wells, F.I.Comer,. (2001). Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain. J Biol Chem 276:9838–45
34. H.N.Ginsberg (2000). Insulin resistance and cardiovascular disease. J Clin Invest 106:453–8
35. H.Goldberg, C.Whiteside, I.G.Fantus (2011). O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells. Am J Physiol Endocrinol Metab 301:E713–26
36. H.J.Goldberg, J.Scholey, I.G.Fantus (2000). Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells. Diabetes 49:863–71
37. H.J.Goldberg, C.I.Whiteside, G.W.Hart, I.G.Fantus (2006). Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 gene expression and Sp1 transcriptional activity in glomerular mesangial cells. Endocrinology 147:222–31
38. Z.Gurel, K.M.Sieg, K.D.Shallow,. (2013). Retinal O-linked N-acetylglucosamine protein modifications: implications for postnatal retinal vascularization and the pathogenesis of diabetic retinopathy. Mol Vis 19:1047–59
39. Z.Gurel, B.W.Zaro, M.R.Pratt, N.Sheibani (2014). Identification of O-GlcNAc modification targets in mouse retinal pericytes: implication of p53 in pathogenesis of diabetic retinopathy. PLoS One 9:e95561
40. J.A.Hanover, S.Yu, W.B.Lubas,. (2003). Mitochondrial and nucleocytoplasmic isoforms of O-linked GlcNAc transferase encoded by a single mammalian gene. Arch Biochem Biophys 409:287–97
41. S.Hardiville, G.W.Hart (2014). Nutrient regulation of signaling, transcription, and cell physiology by O-GlcNAcylation. Cell Metab 20:208–13
42. R.D.Harris, M.W.Steffes, R.W.Bilous,. (1991). Global glomerular sclerosis and glomerular arteriolar hyalinosis in insulin dependent diabetes. Kidney Int 40:107–14
43. G.W.Hart (2013). Nutrient regulation of immunity: O-GlcNAcylation regulates stimulus-specific NF-κB-dependent transcription. Sci Signal 6:pe26
44. G.W.Hart, M.P.Housley, C.Slawson (2007). Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 446:1017–22
45. G.W.Hart, C.Slawson, G.Ramirez-Correa, O.Lagerlof (2011). Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu Rev Biochem 80:825–58
46. L.M.Hartweck, C.L.Scott, N.E.Olszewski (2002). Two O-linked N-acetylglucosamine transferase genes of Arabidopsis thaliana L. Heynh. have overlapping functions necessary for gamete and seed development. Genetics 161:1279–91
47. C.W.Heilig, L.A.Concepcion, B.L.Riser,. (1995). Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Invest 96:1802–14
48. R.H.Hilgers, D.Xing, K.Gong,. (2012). Acute O-GlcNAcylation prevents inflammation-induced vascular dysfunction. Am J Physiol Heart Circ Physiol 303:H513–22
49. G.D.Holt, G.W.Hart (1986). The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc. J Biol Chem 261:8049–57
50. G.D.Holt, C.M.Snow, A.Senior,. (1987). Nuclear pore complex glycoproteins contain cytoplasmically disposed O-linked N-acetylglucosamine. J Cell Biol 104:1157–64
51. M.P.Housley, J.T.Rodgers, N.D.Udeshi,. (2008). O-GlcNAc regulates FoxO activation in response to glucose. J Biol Chem 283:16283–92
52. M.P.Housley, N.D.Udeshi, J.T.Rodgers,. (2009). A PGC-1alpha-O-GlcNAc transferase complex regulates FoxO transcription factor activity in response to glucose. J Biol Chem 284:5148–57
53. Y.Hu, D.Belke, J.Suarez,. (2005). Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart. Circ Res 96:1006–13
54. Y.Hu, J.Suarez, E.Fricovsky,. (2009). Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose. J Biol Chem 284:547–55
55. S.P.Iyer, Y.Akimoto, G.W.Hart (2003). Identification and cloning of a novel family of coiled-coil domain proteins that interact with O-GlcNAc transferase. J Biol Chem 278:5399–409
56. S.P.Jackson, R.Tjian (1988). O-glycosylation of eukaryotic transcription factors: implications for mechanisms of transcriptional regulation. Cell 55:125–33
57. S.Ji, J.G.Kang, S.Y.Park,. (2011). O-GlcNAcylation of tubulin inhibits its polymerization. Amino Acids 40:809–18
58. C.Keembiyehetty, D.C.Love, K.R.Harwood,. (2015). Conditional knock-out reveals a requirement for O-linked N-Acetylglucosaminase (O-GlcNAcase) in metabolic homeostasis. J Biol Chem 290:7097–113
59. M.Kestila, U.Lenkkeri, M.Mannikko,. (1998). Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell 1:575–82
60. R.J.Konrad, J.E.Kudlow (2002). The role of O-linked protein glycosylation in beta-cell dysfunction. Int J Mol Med 10:535–9
61. L.K.Kreppel, M.A.Blomberg, G.W.Hart (1997). Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats. J Biol Chem 272:9308–15
62. L.K.Kreppel, G.W.Hart (1999). Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats. J Biol Chem 274:32015–22
63. M.B.Lazarus, Y.Nam, J.Jiang,. (2011). Structure of human O-GlcNAc transferase and its complex with a peptide substrate. Nature 469:564–7
64. D.M.Lehman, D.J.Fu, A.B.Freeman,. (2005). A single nucleotide polymorphism in MGEA5 encoding O-GlcNAc-selective N-acetyl-beta-D glucosaminidase is associated with type 2 diabetes in Mexican Americans. Diabetes 54:1214–21
65. J.J.Li, S.J.Kwak, D.S.Jung,. (2007). Podocyte biology in diabetic nephropathy. Kidney Int Suppl 106:S36–42
66. D.C.Love, J.Kochan, R.L.Cathey,. (2003). Mitochondrial and nucleocytoplasmic targeting of O-linked GlcNAc transferase. J Cell Sci 116:647–54
67. D.C.Love, M.W.Krause, J.A.Hanover (2010). O-GlcNAc cycling: emerging roles in development and epigenetics. Semin Cell Dev Biol 21:646–54
68. W.A.Lubas, J.A.Hanover (2000). Functional expression of O-linked GlcNAc transferase. Domain structure and substrate specificity. J Biol Chem 275:10983–8
69. B.Luo, Y.Soesanto, D.A.McClain (2008). Protein modification by O-linked GlcNAc reduces angiogenesis by inhibiting Akt activity in endothelial cells. Arterioscler Thromb Vasc Biol 28:651–7
70. M.S.Macauley, X.Shan, S.A.Yuzwa,. (2010). Elevation of Global O-GlcNAc in rodents using a selective O-GlcNAcase inhibitor does not cause insulin resistance or perturb glucohomeostasis. Chem Biol 17:949–58
71. G.M.Magee, R.W.Bilous, C.R.Cardwell,. (2009). Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis. Diabetologia 52:691–7
72. A.Makino, A.Dai, Y.Han,. (2015). O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice. Am J Physiol Cell Physiol 309:C593–9
73. S.A.Marsh, L.J.Dell'Italia, J.C.Chatham (2008). Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice. Amino Acids 40:819–28
74. E.Masson, N.Wiernsperger, M.Lagarde, S.El Bawab (2005). Glucosamine induces cell-cycle arrest and hypertrophy of mesangial cells: implication of gangliosides. Biochem J 388:537–44
75. D.A.McClain, W.A.Lubas, R.C.Cooksey,. (2002). Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia. Proc Natl Acad Sci USA 99:10695–9
76. J.Na, M.T.Sweetwyne, A.S.Park,. (2015). Diet-induced podocyte dysfunction in Drosophila and mammals. Cell Rep 12:636–47
77. S.Ozcan, S.S.Andrali, J.E.Cantrell (2010). Modulation of transcription factor function by O-GlcNAc modification. Biochim Biophys Acta 1799:353–64
78. K.Park, C.D.Saudek, G.W.Hart (2010). Increased expression of beta-N-acetylglucosaminidase in erythrocytes from individuals with pre-diabetes and diabetes. Diabetes 59:1845–50
79. S.Pathak, J.Alonso, M.Schimpl,. (2015). The active site of O-GlcNAc transferase imposes constraints on substrate sequence. Nat Struct Mol Biol 22:744–50
80. G.A.Ramirez-Correa, W.Jin, Z.Wang,. (2008). O-linked GlcNAc modification of cardiac myofilament proteins: a novel regulator of myocardial contractile function. Circ Res 103:1354–8
81. G.A.Ramirez-Correa, J.Ma, C.Slawson,. (2015). Removal of abnormal myofilament O-GlcNAcylation restores Ca2 + sensitivity in diabetic cardiac muscle. Diabetes 64:3573–87
82. S.M.Ranuncolo, S.Ghosh, J.A.Hanover,. (2012). Evidence of the involvement of O-GlcNAc-modified human RNA polymerase II CTD in transcription in vitro and in vivo. J Biol Chem 287:23549–61
83. G.Remuzzi, M.Macia, P.Ruggenenti (2006). Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study. J Am Soc Nephrol 17:S90–7
84. E.P.Roquemore, M.R.Chevrier, R.J.Cotter, G.W.Hart (1996). Dynamic O-GlcNAcylation of the small heat shock protein alpha B-crystallin. Biochemistry 35:3578–86
85. E.P.Roquemore, A.Dell, H.R.Morris,. (1992). Vertebrate lens alpha-crystallins are modified by O-linked N-acetylglucosamine. J Biol Chem 267:555–63
86. R.D.Semba, H.Huang, G.A.Lutty,. (2014). The role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathy. Proteomics Clin Appl 8:218–31
87. R.Shafi, S.P.Iyer, L.G.Ellies,. (2000). The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc Natl Acad Sci USA 97:5735–9
88. H.Shao, C.Wu, A.Wells (2010). Phosphorylation of alpha-actinin 4 upon epidermal growth factor exposure regulates its interaction with actin. J Biol Chem 285:2591–600
89. A.S.Shaw, J.H.Miner (2001). CD2-associated protein and the kidney. Curr Opin Nephrol Hypertens 10:19–22
90. N.Y.Shih, J.Li, V.Karpitskii,. (1999). Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 286:312–15
91. C.Slawson, G.W.Hart (2011). O-GlcNAc signalling: implications for cancer cell biology. Nat Rev Cancer 11:678–84
92. C.Slawson, N.E.Zachara, K.Vosseller,. (2005). Perturbations in O-linked beta-N-acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis. J Biol Chem 280:32944–56
93. E.P.Tan, M.T.Villar, L.EL,. (2014). Altering O-linked β-N-acetylglucosamine cycling disrupts mitochondrial function. J Biol Chem 289:14719–30
94. The Diabetes Control and Complications Trial Research Group. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–86
95. C.Toleman, A.J.Paterson, T.R.Whisenhunt, J.E.Kudlow (2004). Characterization of the histone acetyltransferase (HAT) domain of a bifunctional protein with activable O-GlcNAcase and HAT activities. J Biol Chem 279:53665–73
96. C.R.Torres, G.W.Hart (1984). Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. J Biol Chem 259:3308–17
97. UK Prospective Diabetes Study (UKPDS) Group. (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–53
98. K.Vosseller, L.Wells, M.D.Lane, G.W.Hart (2002). Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 99:5313–18
99. J.L.Walgren, T.S.Vincent, K.L.Schey, M.G.Buse (2003). High glucose and insulin promote O-GlcNAc modification of proteins, including alpha-tubulin. Am J Physiol Endocrinol Metab 284:E424–34
100. Z.Wang, K.Park, F.Comer,. (2009). Site-specific GlcNAcylation of human erythrocyte proteins: potential biomarker(s) for diabetes. Diabetes 58:309–17
101. M.Wei, S.P.Gaskill, S.M.Haffner, M.P.Stern (1998). Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care 21:1167–72
102. S.A.Whelan, W.B.Dias, L.Thiruneelakantapillai,. (2010). Regulation of insulin receptor substrate 1 (IRS-1)/AKT kinase-mediated insulin signaling by O-Linked beta-N-acetylglucosamine in 3T3-L1 adipocytes. J Biol Chem 285:5204–11
103. S.A.Whelan, G.W.Hart (2006). Identification of O-GlcNAc sites on proteins. Meth Enzymol 415:113–33
104. P.W.Wilson, R.B.D'Agostino, D.Levy,. (1998). Prediction of coronary heart disease using risk factor categories. Circulation 97:1837–47
105. A.N.Witmer, G.F.Vrensen, C.J.Van Noorden, R.O.Schlingemann (2003). Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 22:1–29
106. G.Wolf (2000). Cell cycle regulation in diabetic nephropathy. Kidney Int Suppl 77:S59–66
107. G.Wolf, F.N.Ziyadeh (1999). Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 56:393–405
108. X.Yang, P.P.Ongusaha, P.D.Miles,. (2008). Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance. Nature 451:964–9
109. J.W.Yau, S.L.Rogers, R.Kawasaki,. (2012). Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35:556–64
110. Q.Zeidan, Z.Wang, A.De Maio, G.W.Hart (2010). O-GlcNAc cycling enzymes associate with the translational machinery and modify core ribosomal proteins. Mol Biol Cell 21:1922–36
111. X.Zhang, V.Bennett (1996). Identification of O-linked N-acetylglucosamine modification of ankyrinG isoforms targeted to nodes of Ranvier. J Biol Chem 271:31391–8